The term “good distribution practice” refers to the minimum standards that a wholesale distributor must adhere to in order to ensure the continued quality and integrity of medicines throughout the supply chain. GDP also applies to the sourcing, storage, and transportation of active pharmaceutical ingredients and other ingredients used in the pharmaceutical manufacturing process.

GDP compliance enables businesses to ensure that:

• medicines distributed throughout the supply chain are authorised in accordance with European Union (EU) legislation.
• medications are always stored properly, including during transportation.
• contamination by other products or by other substances is avoided.

CyCert conducts audits of companies that manufacture, distribute, and transport medicinal products and ingredients used in the manufacture of the medicines in accordance with the Guidelines of 5 November 2013 on Good Distribution Practices for Medicinal Products for Human Use (2013/C 343/01).

 Conformity Assessment Process / Quotation

For any further information please Contact us